(19)
(11) EP 3 963 092 A1

(12)

(43) Date of publication:
09.03.2022 Bulletin 2022/10

(21) Application number: 20799047.4

(22) Date of filing: 01.05.2020
(51) International Patent Classification (IPC): 
C12Q 1/68(2018.01)
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6883; C12Q 1/6886; C12Q 2600/156
(86) International application number:
PCT/US2020/031089
(87) International publication number:
WO 2020/223657 (05.11.2020 Gazette 2020/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.05.2019 US 201962842064 P
02.05.2019 US 201962842060 P
02.05.2019 US 201962842061 P
02.05.2019 US 201962842066 P

(71) Applicant: Predictive Technology Group, Inc.
Salt Lake City, Utah 84109 (US)

(72) Inventor:
  • WARD, Kenneth
    Salt Lake City, Utah 84109 (US)

(74) Representative: AWA Denmark A/S 
Strandgade 56
1401 Copenhagen K
1401 Copenhagen K (DK)

   


(54) SOMATIC CANCER DRIVER MUTATIONS IN ENDOMETRIOSIS LESIONS CONTRIBUTE TO SECONDARY CANCER RISK